ArticleACS omega2025
Practical, Economical, and Scalable Synthesis of Monoalkyl Oxalates.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The large-scale synthesis of several kinds of monoalyl oxalates, which are half-esters of dialkyl oxalates, under practical and environmentally friendly conditions is described by applying the selective monohydrolysis reaction of symmetric diesters that we reported previously. The most suitable conditions were examined for the kinds of base, equivalent, cosolvent, and reaction time for large-scale production of five kinds of monoalkyl oxalate, monomethyl oxalate, monoethyl oxalate, monopropyl oxalate, monoisopropyl oxalate, and monobutyl oxalate, which are among the most versatile building blocks, but the commercial availabilities are limited. The conditions are mild, simple, and environmentally benign, and the half-esters were produced in high yields, exhibiting high purities in only a few hours without requiring special equipment. Therefore, the synthetic advantage of this reaction is anticipated.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.